A head-to-head comparison of sextant-systematic biopsy vs. extended-systematic biopsy for prostate cancer diagnosis in the era of MRI-targeted biopsy: SEXTANT-PRO non-inferiority randomized clinical trial
Beijing Research Ward Excellence Program (BRWEP2024W054070105), National High Level Hospital Clinical Research Funding (Interdepartmental Research Project of Peking University First Hospital, 2023IR27, 2024IR16).
Authors
- Jiwen Shang (ORCID: https://orcid.org/0000-0003-2971-4683)
- Jianhui Qiu (ORCID: https://orcid.org/0000-0002-4393-612X)
- Jingcheng Zhou (ORCID: https://orcid.org/0000-0002-6226-5667)
- Meixia Shang
- Jingyun Wu (ORCID: https://orcid.org/0000-0002-9182-2127)
- Sibo Tian (ORCID: https://orcid.org/0000-0001-5018-4854)
- Kan Gong
- Ruiyi Deng (ORCID: https://orcid.org/0009-0008-9632-5753)
- Shuai Hu (ORCID: https://orcid.org/0000-0001-5507-1808)
- Qi Shen (ORCID: https://orcid.org/0000-0002-3132-5540)
- Derun Li (ORCID: https://orcid.org/0000-0003-0512-6684)
- Lin Cai
- Yi Liu (ORCID: https://orcid.org/0000-0002-6711-6601)
Institutions
- Peking University (CN)
- Beijing Chest Hospital (CN)
- Peking University First Hospital (CN)
Publication Details
- Journal
- EClinicalMedicine
- Published
- 2025-11-17
- DOI
- https://doi.org/10.1016/j.eclinm.2025.103630
- Citations
- 1
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 1.52
Funders
- Peking University First Hospital
- Peking University